Skip to main content

Advertisement

SpringerLink
Log in

Bisphosphonate use after clinical fracture and risk of new fracture: response to comments by Wu et al.

  • Letter to the Editor
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wu Q-Y, Yuan F-L, Wang B, Li X (2018) Comments on Bergman et al.: Bisphosphonate use after clinical fracture and risk of new fracture. Osteoporos Int. https://doi.org/10.1007/s00198-018-4614-6

  2. Bergman J, Nordstrom A, Nordstrom P (2018) Bisphosphonate use after clinical fracture and risk of new fracture. Osteoporos Int 29:937–945. https://doi.org/10.1007/s00198-017-4367-7

  3. Cummings P (2003) Reporting statistical information in medical journal articles. Arch Pediatr Acolesc Med 157:321–324. https://doi.org/10.1001/archpedi.157.4.321

    Article  Google Scholar 

  4. Brozek W, Reichardt B, Zwerina J, Dimai HP, Klaushofer K, Zwettler E (2016) Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study. Osteoporos Int 27:387–396. https://doi.org/10.1007/s00198-015-3415-4

    Article  PubMed  CAS  Google Scholar 

  5. Bondo L, Eiken P, Abrahamsen B (2013) Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study. Osteoporos Int 24:245–252. https://doi.org/10.1007/s00198-012-2024-8

    Article  PubMed  CAS  Google Scholar 

  6. Abrahamsen B, Eiken P, Eastell R (2009) Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res 24:1095–1102. https://doi.org/10.1016/S0276-1092(10)79672-3

    Article  PubMed  CAS  Google Scholar 

  7. MacLean C, Maglione M, McMahon M et al (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148:97–213. https://doi.org/10.7326/0003-4819-148-3-200802050-00198

    Article  Google Scholar 

  8. Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Booth MJ, Motala A, Shekelle PG (2014) Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review. Ann Intern Med 161:711–723. https://doi.org/10.7326/M14-0317

    Article  PubMed  Google Scholar 

  9. Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Howe TS, van der Meulen MCH, Weinstein RS, Whyte MP (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1–23. https://doi.org/10.1002/jbmr.1998

    Article  PubMed  Google Scholar 

  10. Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler PJ, Laupacis A (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 305:783–789. https://doi.org/10.1001/jama.2011.190

    Article  PubMed  CAS  Google Scholar 

  11. Abrahamsen B, Eiken P, Prieto-Alhambra D, Eastell R (2016) Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study. BMJ 353:i3365. https://doi.org/10.1136/bmj.i3365

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by the Swedish Research Council (2016-02584).

Author information

Authors and Affiliations

  1. Department of Community Medicine and Rehabilitation, Unit of Geriatric Medicine, Umeå University, 90187, Umeå, Sweden

    J. Bergman & P. Nordström

  2. Department of Public Health and Clinical Medicine, Unit of Occupational and Environmental Medicine, Umeå University, Umeå, Sweden

    A. Nordström

  3. School of Sport Sciences, Arctic University of Norway, Tromsø, Norway

    A. Nordström

Authors
  1. J. Bergman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Nordström
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Nordström
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Nordström.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bergman, J., Nordström, A. & Nordström, P. Bisphosphonate use after clinical fracture and risk of new fracture: response to comments by Wu et al.. Osteoporos Int 29, 2159–2160 (2018). https://doi.org/10.1007/s00198-018-4615-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-018-4615-5

Search

Navigation